In the ATTAIN-1 trial, participants who received the highest dose of Foundayo and completed treatment lost an average of 27.3 pounds (12.4%), compared with only 2.2 pounds (0.9%) with placebo
Adinolfi S, Patinen T, Deen AJ, Pitknen S, Hrknen J, Kansanen E, et al
Elucidating compound mechanism of action by network perturbation analysis
References Angl, S., Engblom, J., Eriksson, T., Kautiainen, S., Saha, M.-T., Lindfors, P., Lehtinen, M., & Rimpel, A
This long-acting amylin analogue promotes feelings of fullness, thereby reducing the tendency to overeat
Each MDLifespan protocol shares the same PlasmaXchange foundation, ensuring powerful detoxification across a range of health concerns